Inmolecule Nanotech (XPAR:MLINA) ROCE %: -2.10% (As of Dec. 2024)


XPAR:MLINA Inmolecule Nanotech SA XPAR:MLINA
6 GF Score
Price €4.08
! 2 Warning Signs
View Full Analysis

What is Inmolecule Nanotech ROCE %?

Inmolecule Nanotech XPAR:MLINA 6 ROCE % is -2.10% as of Dec. 2024. GuruFocus rates XPAR:MLINA with a GF Score™ of 6/100. The stock has 2 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Inmolecule Nanotech's annualized ROCE % for the quarter that ended in Dec. 2024 was -2.10%.

Inmolecule Nanotech  (XPAR:MLINA) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Inmolecule Nanotech ROCE % Related Terms

Inmolecule Nanotech ROCE % Historical Data

* Premium members only.

The historical data trend for Inmolecule Nanotech's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Inmolecule Nanotech ROCE % Chart

Inmolecule Nanotech Annual Data
Trend Dec23 Dec24
ROCE %
-14.53 -2.10

Inmolecule Nanotech Semi-Annual Data
Dec23 Dec24
ROCE % -14.53 -2.10
XPAR:MLINA
6GF Score
Inmolecule Nanotech SA XPAR:MLINA
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Inmolecule Nanotech ROCE % Calculation

Inmolecule Nanotech's annualized ROCE % for the fiscal year that ended in Dec. 2024 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2024 )  (A: Dec. 2023 )(A: Dec. 2024 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2024 )  (A: Dec. 2023 )(A: Dec. 2024 )
=-0.217/( ( (14.42 - 3.134) + (12.303 - 2.908) )/ 2 )
=-0.217/( (11.286+9.395)/ 2 )
=-0.217/10.3405
=-2.10 %

Inmolecule Nanotech's ROCE % of for the quarter that ended in Dec. 2024 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2024 )  (Q: Dec. 2023 )(Q: Dec. 2024 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2024 )  (Q: Dec. 2023 )(Q: Dec. 2024 )
=-0.217/( ( (14.42 - 3.134) + (12.303 - 2.908) )/ 2 )
=-0.217/( ( 11.286 + 9.395 )/ 2 )
=-0.217/10.3405
=-2.10 %

(1) Note: The EBIT data used here is one times the annual (Dec. 2024) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -2.10% mean?
Inmolecule Nanotech (XPAR:MLINA) has a ROCE % of -2.10% as of Dec. 2024.
Is Inmolecule Nanotech's ROCE % too high?
Inmolecule Nanotech's current ROCE % is -2.10%. Overall, Inmolecule Nanotech has a GF Score™ of 6/100, reflecting its overall financial health beyond just this single metric.
How does Inmolecule Nanotech's ROCE % compare to VRTX and REGN?
Inmolecule Nanotech's ROCE % of -2.10% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Biotechnology company?
A good ROCE % depends on the Biotechnology industry context. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. Inmolecule Nanotech's current ROCE % is -2.10%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Inmolecule Nanotech stock overvalued right now?
Inmolecule Nanotech (XPAR:MLINA) has a current ROCE % of -2.10%. The current ROCE % is -2.10%. Inmolecule Nanotech's overall GF Score™ is 6/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Inmolecule Nanotech (XPAR:MLINA), the current ROCE % is -2.10% as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Inmolecule Nanotech Business Description

Address Paseo de la Castellana 91, 4th Floor, Madrid, ESP, 28046
Inmolecule Nanotech SA is a research and development company. The company provides health care, home care and personal care products.
6GF Score

Get the complete analysis for XPAR:MLINA

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.08
Price